To examine the effect of Src-mediated phosphorylation of lamin A on nuclear morphology, human breast cancer cell lines MCF7 and MDA-MB-231 were treated with the selective Src inhibitor dasatinib. The gene discussed is SRC; the disease is breast carcinoma.